::: {.hero-section .column-screen}
```{=html}
  <div class="hero-text">
    <h2>Leveraging the gut immune system to deliver precision cytotoxic immunotherapies</h2>
    <h5>Our approach combines the convenience of oral administration with the power of a targeted T-cell response</h5>
    <a href="technology.qmd" class="btn btn-primary btn-lg mt-4">MORE</a>
  </div>
```
:::

::: {.content-section .section-pioneering .column-screen}
<div class="container">
## New Class of Cytotoxic Immunotherapies {.text-center}

::: {.text-center .mt-4}
[Learn more about VAXIMM technology](technology.qmd){.btn .btn-outline-light}
:::
</div>
:::

::: {.content-section .section-pipeline .column-screen}
<div class="container">
## Robust Development Pipeline to Address Clinically-Validated Targets with Novel Immunotherapies {.text-center}

::: {.text-center .mt-4}
[Learn more about our pipeline](pipeline.qmd){.btn .btn-outline-light}
:::
</div>
:::

::: {.content-section .section-leadership .column-screen}
<div class="container">
## Corporate Vision and Mission Scientifically Grounded by Founding Leadership {.text-center}

::: {.text-center .mt-4}
[Learn more about us](about.qmd){.btn .btn-outline-light}
:::
</div>
:::
